GO
Loading...

Amgen Inc

More

  • US STOCKS-Earnings lift Wall St despite mixed data Tuesday, 28 Oct 2014 | 12:00 PM ET

    *Twitter falls; Madison Square Garden up on possible split. *Capital goods orders post largest fall in eight months. Ranking among the largest percentage gainers on the S&P 500 were Amgen, AutoNation and Cummins, which reported earnings between late Monday and Tuesday morning.

  • Amgen CEO: We're not splitting up Tuesday, 28 Oct 2014 | 11:31 AM ET
    Amgen building in South San Francisco, California.

    Amgen's CEO provided an answer to Dan Loeb's recent suggestion that the biotechnology company be split up. In short, he said, it doesn't make sense.

  • US STOCKS-Wall St up on earnings, data mixed Tuesday, 28 Oct 2014 | 10:52 AM ET

    *Capital goods orders post largest fall in eight months. NEW YORK, Oct 28- U.S. stocks rose on Tuesday as strong earnings and an upbeat consumer confidence reading more than offset weaker-than-expected housing and industrial data. Ranking among the largest percentage gainers on the S&P 500 were Amgen, AutoNation and Cummins, which reported earnings between...

  • Amgen CEO: Not planning on split  Tuesday, 28 Oct 2014 | 9:13 AM ET

    At Amgen's investor meeting, CNBC's Meg Tirrell reports CEO Bob Bradway said the company considered splitting up but does not see it adding value right now.

  • Early Movers: DD, PFE, AET, TWTR, MSG, WMT & more Tuesday, 28 Oct 2014 | 8:07 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Oct 28- Pfizer Inc reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans in the wake of its recent failed efforts to buy rival British drugmaker AstraZeneca Plc. Excluding special items, Pfizer earned 57 cents per share.

  • LONDON, Oct 28- U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer. Better information about their structure could help in the hunt for new drug candidates, the partners in the new GPCR Consortium believe.

  • After-hours buzz: Amgen, Crocs, Twitter & more Monday, 27 Oct 2014 | 4:53 PM ET

    Check out which companies are making headlines after the bell Monday: Amgen, Crocs, Twitter & more.

  • Oct 27- Amgen Inc on Monday reported higher-than-expected third quarter profit and revenue, helped by strong demand for its white blood cell booster, Neulasta, and increased sales of newer drugs, and the company raised its full-year forecast. Amgen shares are up almost 20 percent since the restructuring announcement that involved plant closings and the...

  • Amgen beats Street, raises full-year forecasts Monday, 27 Oct 2014 | 4:01 PM ET
    Amgen offices in Fremont, Calif.

    Amgen reported better-than expected quarterly results and said it projects full-year earnings and revenue to come in above analysts' forecasts.

  • Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...

  • US stocks and sectors to watch after NY Ebola case Friday, 24 Oct 2014 | 4:45 AM ET
    Traders on the floor of the New York Stock Exchange.

    Global equity strategists pick out U.S. sectors and stocks that could be affected in Friday's trading session on the back of the NY Ebola case.

  • Lightning Round: What's the next best play? Wednesday, 22 Oct 2014 | 7:27 PM ET

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Your first trade for Thursday Wednesday, 22 Oct 2014 | 6:03 PM ET

    The "Fast Money" traders share their final trades of the day.

  • Larry Fink: Wall Street needs to help society Wednesday, 22 Oct 2014 | 11:03 AM ET
    Larry Fink, CEO of BlackRock Investments.

    Big name investors like Dan Loeb and David Einhorn helped raise $6 million to fight poverty at a charity event in New York City.

  • BOSTON, Oct 21- Hedge fund manager Daniel Loeb told investors on Tuesday he urged U.S. biotechnology company Amgen Inc to split into two separate businesses, a move he said could boost its share price by more than 80 percent. "Our own extensive diligence suggests that a breakup of Amgen is feasible and that purported constraints such as tax strategy and supply...

  • Dan Loeb talks up Amgen stake; shares rise Tuesday, 21 Oct 2014 | 3:02 PM ET
    Daniel Loeb

    Hedge fund manager Dan Loeb recommended Amgen's stock Tuesday, causing shares to rise on the news.

  • WASHINGTON, Oct 16- Medicine costs would rise if draft proposals in a Pacific Rim trade pact come into force, health and consumer rights advocates said on Thursday after the release of a leaked negotiating text. The TPP's 12 members range from the United States and Japan to Malaysia and Vietnam, where equitable access to medicine is a priority, and Australia and...

  • Oct 16- The benefits of Novartis AG's anti-inflammation drug outweighed the risks in using it to treat a type of psoriasis, staff reviewers at the U.S. Food and Drug Administration said. There were no major safety issues associated with secukinumab, according to the review posted on the FDA website on Thursday- four days before a panel of outside advisers is...

  • Oct 16- The benefits of Novartis AG's anti-inflammation drug outweighed the risks in using it to treat a type of psoriasis, staff reviewers at the U.S. Food and Drug Administration said. While the FDA is not obligated to accept the recommendations of the panel, it typically does so. The FDA staff based its recommendation on the review of the data from this study,...